Literature DB >> 20538041

Curcuminoids enhance memory in an amyloid-infused rat model of Alzheimer's disease.

T Ahmed1, S A Enam, A H Gilani.   

Abstract

Alzheimer's disease (AD) is a neurodegenerative disease. There are a limited number of therapeutic options available for the treatment of AD. Curcuminoids (a mixture of bisdemethoxycurcumin, demethoxycurcumin and curcumin) is the main chemical constituent found in turmeric, a well known curry spice, having potential in the treatment of AD. The objective of this study was to investigate the effects of curcuminoid mixture and individual constituents on spatial learning and memory in an amyloid-beta (Abeta) peptide-infused rat model of AD and on the expression of PSD-95, synaptophysin and camkIV. Curcuminoid mixture showed a memory-enhancing effect in rats displaying AD-like neuronal loss only at 30 mg/kg, whereas individual components were effective at 3-30 mg/kg. A shorter duration treatment with test compounds showed that the curcuminoid mixture and bisdemethoxycurcumin increased PSD-95 expression in the hippocampus at 3-30 mg/kg, with maximum effect at a lower dose (3 mg/kg) with respective values of 470.5 and 587.9%. However, after a longer duration treatment, two other compounds (demethoxycurcumin and curcumin) also increased PSD-95 to 331.7 and 226.2% respectively at 30 mg/kg. When studied for their effect on synaptophysin in the hippocampus after the longer duration treatment, the curcuminoid mixture and all three individual constituents increased synaptophysin expression. Of these, demethoxycurcumin was the most effective showing a 350.1% increase (P<0.01) at 30 mg/kg compared to the neurotoxin group. When studied for their effect on camkIV expression after longer treatment in the hippocampus, only demethoxycurcumin at 30 mg/kg increased levels to 421.2%. These compounds salvaged PSD-95, synaptophysin and camkIV expression levels in the hippocampus in the rat AD model, which suggests multiple target sites with the potential of curcuminoids in spatial memory enhancing and disease modifying in AD. Copyright (c) 2010 IBRO. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20538041     DOI: 10.1016/j.neuroscience.2010.05.078

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  37 in total

1.  Amyloid fibrils induce dysfunction of hippocampal glutamatergic silent synapses.

Authors:  Bihua Bie; Jiang Wu; Joseph F Foss; Mohamed Naguib
Journal:  Hippocampus       Date:  2018-05-07       Impact factor: 3.899

2.  Memory-enhancing effect of aspirin is mediated through opioid system modulation in an AlCl3-induced neurotoxicity mouse model.

Authors:  Saima Rizwan; Ayesha Idrees; Muhammad Ashraf; Touqeer Ahmed
Journal:  Exp Ther Med       Date:  2016-03-11       Impact factor: 2.447

Review 3.  Animal models in the drug discovery pipeline for Alzheimer's disease.

Authors:  Debby Van Dam; Peter Paul De Deyn
Journal:  Br J Pharmacol       Date:  2011-10       Impact factor: 8.739

Review 4.  Adaptive cellular stress pathways as therapeutic targets of dietary phytochemicals: focus on the nervous system.

Authors:  Jaewon Lee; Dong-Gyu Jo; Daeui Park; Hae Young Chung; Mark P Mattson
Journal:  Pharmacol Rev       Date:  2014-07       Impact factor: 25.468

Review 5.  Supplemental substances derived from foods as adjunctive therapeutic agents for treatment of neurodegenerative diseases and disorders.

Authors:  Gregory E Bigford; Gianluca Del Rossi
Journal:  Adv Nutr       Date:  2014-07-14       Impact factor: 8.701

6.  Epigenetic modulation of Cdk5 contributes to memory deficiency induced by amyloid fibrils.

Authors:  Liuhong Li; Chunqiang Zhang; Xiaohong Zi; Qiuyun Tu; Ke Guo
Journal:  Exp Brain Res       Date:  2014-09-19       Impact factor: 1.972

7.  Epigenetic suppression of neuroligin 1 underlies amyloid-induced memory deficiency.

Authors:  Bihua Bie; Jiang Wu; Hui Yang; Jijun J Xu; David L Brown; Mohamed Naguib
Journal:  Nat Neurosci       Date:  2014-01-19       Impact factor: 24.884

8.  Ibuprofen targets neuronal pentraxins expresion and improves cognitive function in mouse model of AlCl3-induced neurotoxicity.

Authors:  Anum Jamil; Aamra Mahboob; Touqeer Ahmed
Journal:  Exp Ther Med       Date:  2015-12-10       Impact factor: 2.447

9.  Genistein Inhibits Aβ25-35-Induced Synaptic Toxicity and Regulates CaMKII/CREB Pathway in SH-SY5Y Cells.

Authors:  Yuan-Di Xi; Dan-Di Zhang; Juan Ding; Huan-Ling Yu; Lin-Hong Yuan; Wei-Wei Ma; Jing Han; Rong Xiao
Journal:  Cell Mol Neurobiol       Date:  2015-12-11       Impact factor: 5.046

Review 10.  Autophagy and neuronal cell death in neurological disorders.

Authors:  Ralph A Nixon; Dun-Sheng Yang
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-10-01       Impact factor: 10.005

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.